Hypomagnesemia associated with chemotherapy in patients treated for acute lymphoblastic leukemia: Possible mechanisms

Oncology Reports

Volumn 11, Issue 1, 2004, Pages 185-189

  Guo, Chun Yuan ^a   Halton, Jacqueline M ^a,b,c   Barr, Ronald D ^a,b   Atkinson, Stephanie A ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

^c CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

Acute lymphoblastic leukemia; Bone metabolism; Corticosteroids; Magnesium homeostasis

Indexed keywords

ANTINEOPLASTIC AGENT; OSTEOCALCIN;

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; BLOOD; BONE DENSITY; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; CHILD; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; HUMAN; INFANT; LONGITUDINAL STUDY; MAGNESIUM DEFICIENCY; MALE; PRESCHOOL CHILD; TIME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE DENSITY; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; LONGITUDINAL STUDIES; MAGNESIUM DEFICIENCY; MALE; OSTEOCALCIN; TIME FACTORS;

EID: 3543141919     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.11.1.185     Document Type: Article

References (26)

1. O'Regan S, Carson S, Chesney RW and Drummond KN: Electrolyte and acid-base disturbance in the management of leukemia (editorial review). Blood 49: 345-354, 1977.
2. Freedman DB, Shannon M, Dandona P, Prentice HG and Hoffbrand AV: Hypoparathyroidism and hypocalcaemia during treatment for acute leukaemia. Br Med J 284: 700-702, 1982. (Pubitemid 12176821)
3. Halton JM, Atkinson SA, Fraher L, Webber CE, Cockshott WP, Tam C and Barr RD: Mineral homeostasis and bone mass at diagnosis in children with acute lymphoblastic leukemia. J Pediatr 126: 557-564, 1995.
4. Halton JM, Atkinson SA, Fraher L, Webber C, Gill GJ, Dawson S and Barr RD: Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. J Bone Min Res 11: 1774-1782, 1996.
5. Wu B, Atkinson SA, Halton JM and Barr RD: Hypermagnesiuria and hypercalciuria in childhood leukemia: an effect of amikacin therapy. J Pediatr Hematol/Oncol 18: 86-89, 1996. (Pubitemid 26048531)
6. Kelnar CJH, Toar WS, Reynolds DJ, Smith DR, Slavin BM and Brook CGD: Hypomagnesemic hypocalcemia with hypokalemia caused by treatment with high dose gentamicin. Arch Dis Child 53: 817-820, 1978. (Pubitemid 9008339)
7. Bar RS, Wilson HE and Mazzaferri EL: Hypomagnesemic hypocalcemia secondary to renal magnesium wasting: a possible consequence of high dose gentamicin therapy. Ann Intern Med 82: 646-649, 1975.
8. Mendoza SA: Nephrotoxic drugs. Pediatr Nephrol 2: 466-476, 1988.
9. Atkinson S, Halton J, Bradley C, Wu B and Barr RD: Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: influence of disease, drugs and nutrition. Int J Cancer 11: 35-38, 1998.
10. Steindig-Lindberg G, Tepper R and Leichter I: Trabecular bone density in a 2-year trial of peroral magnesium in osteoporosis. Magnesium Res 6: 155-163, 1993.
11. Abbott L, Nadler J and Rude PK: Magnesium in alcoholism: possible contribution to osteoporosis and cardiovascular disease in alcoholics. Alcohol Clin Exp Res 18: 1076-1082, 1994. (Pubitemid 24345510)
12. Rude PK and Olerich M: Magnesium deficiency: possible role in osteoporosis associated with gluten-sensitive enteropathy. Osteoporosis Int 6: 453-461, 1996.
13. Barr RD: Acute leukemia in childhood. In: Current Therapy in Hematology-Oncology. Brain MC and Carbone PP (eds). B.C. Decker, Inc., Toronto, pp71-78, 1988.
14. Atkinson SA, Halton JM, Hay J, Gordon C and Webber C: Normative values for lumbar spine bone mass in children in relation to age, gender, dietary intake and physical activity. J Bone Min Res 6 (Suppl): A196, 1991.
15. MacIntyre I: Flame photometry. Adv Clin Chem 4: 1-28, 1961.
16. Canalis E: Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 81: 3441-3447, 1996.
17. Ip M, Lam K, Yam L, Kung A and Ng M: Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids. Chest 105: 1722-1727, 1994. (Pubitemid 24180658)
18. Sambrook PN, Birmingam J and Kelly P: Prevention of corticosteroid osteoporosis: a comparison of calcium, calcitriol and calcitonin. N Engl J Med 328: 1747-1752, 1993.
19. Durlach J: Magnesium in clinical practice. John Libbey and Co., Ltd., London, p40, 1988.
20. Iligin G: Serum copper and magnesium levels in leukemia and malignant lymphoma. Lancet 2: 1036-1037, 1971.
21. Ward WE and Atkinson SA: Growth hormone and insulin-like growth factor-I therapy promote protein deposition and growth in dexamethasone-treated piglets. J Pediatr Gastroenterol Nutr 28: 404-410, 1999. (Pubitemid 30349250)
22. Van Goudoever JB, Wattimena JDL, Carnielli VP, Sulkers EJ, Degenhart HJ and Sauer PJJ: Effect of dexamethasone on protein metabolism in infants with bronchopulmonary dysplasia. J Pediatr 124: 112-118, 1994. (Pubitemid 24027298)
23. Manolagas SC and Weinstein RS: New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Min Res 14: 1061-1066, 1999. (Pubitemid 29314048)
24. Gordon CL, Halton JM, Atkinson SA and Webber CE: The contributions of growth and puberty to peak bone mass. Growth Develop Aging 55: 257-262, 1991.
25. Arikoski P, Komulainen J, Riikonen P, Voutilainen R, Knip M and Kroger H: Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: an 1-year prospective study. J Clin Endocrinol Metab 84: 3174-3181, 1999. (Pubitemid 30646940)
26. Breslau NA: Calcium, magnesium, and phosphorus: renal handling and urinary excretion. In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Favus MJ (ed). Lippincott-Raven Publishers, Philadelphia, pp2-53, 1996.